Global Inactivated Polio Virus Vaccine Market Growth (Status and Outlook) 2022-2028
- LP 4970149
- 62 Pages
- June 2022
- Pharmaceuticals
The United States Inactivated Polio Virus Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Inactivated Polio Virus Vaccine market, reaching US$ million by the year 2028. As for the Europe Inactivated Polio Virus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Inactivated Polio Virus Vaccine players cover Sanofi, GSK, Serum Institute (Bilthoven Biologicals), and IMBCA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Polio Virus Vaccine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Type I
Type II
Type III
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inactivated Polio Virus Vaccine Market Size 2017-2028
2.1.2 Inactivated Polio Virus Vaccine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Inactivated Polio Virus Vaccine Segment by Type
2.2.1 Type I
2.2.2 Type II
2.2.3 Type III
2.3 Inactivated Polio Virus Vaccine Market Size by Type
2.3.1 Inactivated Polio Virus Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
2.4 Inactivated Polio Virus Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Inactivated Polio Virus Vaccine Market Size by Application
2.5.1 Inactivated Polio Virus Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
3 Inactivated Polio Virus Vaccine Market Size by Player
3.1 Inactivated Polio Virus Vaccine Market Size Market Share by Players
3.1.1 Global Inactivated Polio Virus Vaccine Revenue by Players (2020-2022)
3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2020-2022)
3.2 Global Inactivated Polio Virus Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Inactivated Polio Virus Vaccine by Regions
4.1 Inactivated Polio Virus Vaccine Market Size by Regions (2017-2022)
4.2 Americas Inactivated Polio Virus Vaccine Market Size Growth (2017-2022)
4.3 APAC Inactivated Polio Virus Vaccine Market Size Growth (2017-2022)
4.4 Europe Inactivated Polio Virus Vaccine Market Size Growth (2017-2022)
4.5 Middle East & Africa Inactivated Polio Virus Vaccine Market Size Growth (2017-2022)
5 Americas
5.1 Americas Inactivated Polio Virus Vaccine Market Size by Country (2017-2022)
5.2 Americas Inactivated Polio Virus Vaccine Market Size by Type (2017-2022)
5.3 Americas Inactivated Polio Virus Vaccine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Polio Virus Vaccine Market Size by Region (2017-2022)
6.2 APAC Inactivated Polio Virus Vaccine Market Size by Type (2017-2022)
6.3 APAC Inactivated Polio Virus Vaccine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Inactivated Polio Virus Vaccine by Country (2017-2022)
7.2 Europe Inactivated Polio Virus Vaccine Market Size by Type (2017-2022)
7.3 Europe Inactivated Polio Virus Vaccine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inactivated Polio Virus Vaccine by Region (2017-2022)
8.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Type (2017-2022)
8.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Inactivated Polio Virus Vaccine Market Forecast
10.1 Global Inactivated Polio Virus Vaccine Forecast by Regions (2023-2028)
10.1.1 Global Inactivated Polio Virus Vaccine Forecast by Regions (2023-2028)
10.1.2 Americas Inactivated Polio Virus Vaccine Forecast
10.1.3 APAC Inactivated Polio Virus Vaccine Forecast
10.1.4 Europe Inactivated Polio Virus Vaccine Forecast
10.1.5 Middle East & Africa Inactivated Polio Virus Vaccine Forecast
10.2 Americas Inactivated Polio Virus Vaccine Forecast by Country (2023-2028)
10.2.1 United States Inactivated Polio Virus Vaccine Market Forecast
10.2.2 Canada Inactivated Polio Virus Vaccine Market Forecast
10.2.3 Mexico Inactivated Polio Virus Vaccine Market Forecast
10.2.4 Brazil Inactivated Polio Virus Vaccine Market Forecast
10.3 APAC Inactivated Polio Virus Vaccine Forecast by Region (2023-2028)
10.3.1 China Inactivated Polio Virus Vaccine Market Forecast
10.3.2 Japan Inactivated Polio Virus Vaccine Market Forecast
10.3.3 Korea Inactivated Polio Virus Vaccine Market Forecast
10.3.4 Southeast Asia Inactivated Polio Virus Vaccine Market Forecast
10.3.5 India Inactivated Polio Virus Vaccine Market Forecast
10.3.6 Australia Inactivated Polio Virus Vaccine Market Forecast
10.4 Europe Inactivated Polio Virus Vaccine Forecast by Country (2023-2028)
10.4.1 Germany Inactivated Polio Virus Vaccine Market Forecast
10.4.2 France Inactivated Polio Virus Vaccine Market Forecast
10.4.3 UK Inactivated Polio Virus Vaccine Market Forecast
10.4.4 Italy Inactivated Polio Virus Vaccine Market Forecast
10.4.5 Russia Inactivated Polio Virus Vaccine Market Forecast
10.5 Middle East & Africa Inactivated Polio Virus Vaccine Forecast by Region (2023-2028)
10.5.1 Egypt Inactivated Polio Virus Vaccine Market Forecast
10.5.2 South Africa Inactivated Polio Virus Vaccine Market Forecast
10.5.3 Israel Inactivated Polio Virus Vaccine Market Forecast
10.5.4 Turkey Inactivated Polio Virus Vaccine Market Forecast
10.5.5 GCC Countries Inactivated Polio Virus Vaccine Market Forecast
10.6 Global Inactivated Polio Virus Vaccine Forecast by Type (2023-2028)
10.7 Global Inactivated Polio Virus Vaccine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Inactivated Polio Virus Vaccine Product Offered
11.1.3 Sanofi Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Inactivated Polio Virus Vaccine Product Offered
11.2.3 GSK Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Serum Institute (Bilthoven Biologicals)
11.3.1 Serum Institute (Bilthoven Biologicals) Company Information
11.3.2 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Offered
11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Serum Institute (Bilthoven Biologicals) Main Business Overview
11.3.5 Serum Institute (Bilthoven Biologicals) Latest Developments
11.4 IMBCA
11.4.1 IMBCA Company Information
11.4.2 IMBCA Inactivated Polio Virus Vaccine Product Offered
11.4.3 IMBCA Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 IMBCA Main Business Overview
11.4.5 IMBCA Latest Developments
12 Research Findings and Conclusion
Table 1. Inactivated Polio Virus Vaccine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Type I
Table 3. Major Players of Type II
Table 4. Major Players of Type III
Table 5. Inactivated Polio Virus Vaccine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
Table 8. Inactivated Polio Virus Vaccine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
Table 11. Global Inactivated Polio Virus Vaccine Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Inactivated Polio Virus Vaccine Revenue Market Share by Player (2020-2022)
Table 13. Inactivated Polio Virus Vaccine Key Players Head office and Products Offered
Table 14. Inactivated Polio Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Inactivated Polio Virus Vaccine Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Inactivated Polio Virus Vaccine Market Size Market Share by Regions (2017-2022)
Table 19. Americas Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Country (2017-2022)
Table 21. Americas Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
Table 23. Americas Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
Table 25. APAC Inactivated Polio Virus Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Region (2017-2022)
Table 27. APAC Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
Table 29. APAC Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
Table 31. Europe Inactivated Polio Virus Vaccine Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Country (2017-2022)
Table 33. Europe Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
Table 35. Europe Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Inactivated Polio Virus Vaccine
Table 44. Key Market Challenges & Risks of Inactivated Polio Virus Vaccine
Table 45. Key Industry Trends of Inactivated Polio Virus Vaccine
Table 46. Global Inactivated Polio Virus Vaccine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Inactivated Polio Virus Vaccine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Inactivated Polio Virus Vaccine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sanofi Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 53. Sanofi Inactivated Polio Virus Vaccine Product Offered
Table 54. Sanofi Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. GSK Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 58. GSK Inactivated Polio Virus Vaccine Product Offered
Table 59. GSK Main Business
Table 60. GSK Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. GSK Latest Developments
Table 62. Serum Institute (Bilthoven Biologicals) Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 63. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Offered
Table 64. Serum Institute (Bilthoven Biologicals) Main Business
Table 65. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Serum Institute (Bilthoven Biologicals) Latest Developments
Table 67. IMBCA Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 68. IMBCA Inactivated Polio Virus Vaccine Product Offered
Table 69. IMBCA Main Business
Table 70. IMBCA Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. IMBCA Latest Developments
List of Figures
Figure 1. Inactivated Polio Virus Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inactivated Polio Virus Vaccine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Inactivated Polio Virus Vaccine Market Size Market Share by Type in 2021
Figure 7. Inactivated Polio Virus Vaccine in Hospital
Figure 8. Global Inactivated Polio Virus Vaccine Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Inactivated Polio Virus Vaccine in Clinic
Figure 10. Global Inactivated Polio Virus Vaccine Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Global Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2021
Figure 12. Global Inactivated Polio Virus Vaccine Revenue Market Share by Player in 2021
Figure 13. Global Inactivated Polio Virus Vaccine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Inactivated Polio Virus Vaccine Market Size 2017-2022 ($ Millions)
Figure 15. APAC Inactivated Polio Virus Vaccine Market Size 2017-2022 ($ Millions)
Figure 16. Europe Inactivated Polio Virus Vaccine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Inactivated Polio Virus Vaccine Market Size 2017-2022 ($ Millions)
Figure 18. Americas Inactivated Polio Virus Vaccine Value Market Share by Country in 2021
Figure 19. Americas Inactivated Polio Virus Vaccine Consumption Market Share by Type in 2021
Figure 20. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2021
Figure 21. United States Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Region in 2021
Figure 26. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2021
Figure 27. China Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Country in 2021
Figure 34. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Type in 2021
Figure 35. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2021
Figure 36. Germany Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2021
Figure 44. Egypt Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Inactivated Polio Virus Vaccine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 50. APAC Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 51. Europe Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 53. United States Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 54. Canada Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 57. China Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 58. Japan Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 59. Korea Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 61. India Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 62. Australia Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 63. Germany Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 64. France Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 65. UK Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 66. Italy Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 67. Russia Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 68. Spain Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 71. Israel Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Inactivated Polio Virus Vaccine Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
